Characterization of a nonvirulent variant of lymphocytic choriomeningitis virus

Area of Science:

• Virology
• Immunology
• Neuroscience

Background:

• Lymphocytic choriomeningitis virus (LCMV) is a significant human and animal pathogen.
• The Armstrong strain of LCMV is a well-characterized model for studying viral pathogenesis and immunity.
• Developing safe and effective viral vaccine candidates is crucial for public health.

Purpose of the Study:

• To isolate and characterize a cold-adapted, nonvirulent variant of the LCMV Armstrong strain.
• To evaluate the neurotropic and immunogenic properties of the isolated variant in a mouse model.
• To assess the protective efficacy of the variant against challenge with the virulent parental strain.

Main Methods:

• Isolation of a viral variant from infected L929 cells cultured at 25°C.
• Intracranial inoculation of mice to assess neurovirulence and replication.
• Intraperitoneal challenge with the parental LCMV Armstrong strain to evaluate protective immunity.

Main Results:

• A cold-adapted, nonvirulent LCMV variant, designated P17, was successfully isolated.
• P17 replicated within the central nervous system of mice without inducing observable disease.
• Mice infected with P17 were protected from subsequent lethal challenge with the virulent LCMV Armstrong strain.

Conclusions:

• The P17 variant represents a promising candidate for a live-attenuated LCMV vaccine.
• The P17 variant demonstrates neuroattenuation and potent immunogenicity.
• Further studies are warranted to explore the full therapeutic and prophylactic potential of P17.